nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CYP2B6—Thiotepa—urinary bladder cancer	0.133	0.218	CbGbCtD
Clopidogrel—ABCB1—Mitomycin—urinary bladder cancer	0.0898	0.148	CbGbCtD
Clopidogrel—CYP3A4—Thiotepa—urinary bladder cancer	0.0408	0.0671	CbGbCtD
Clopidogrel—CYP2B6—Cisplatin—urinary bladder cancer	0.0366	0.0603	CbGbCtD
Clopidogrel—CYP2C8—Fluorouracil—urinary bladder cancer	0.0327	0.0537	CbGbCtD
Clopidogrel—CYP3A5—Etoposide—urinary bladder cancer	0.0284	0.0466	CbGbCtD
Clopidogrel—CYP2C8—Etoposide—urinary bladder cancer	0.0273	0.0449	CbGbCtD
Clopidogrel—ABCB1—Gemcitabine—urinary bladder cancer	0.0259	0.0425	CbGbCtD
Clopidogrel—CYP1A2—Fluorouracil—urinary bladder cancer	0.0253	0.0416	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—urinary bladder cancer	0.0246	0.0404	CbGbCtD
Clopidogrel—CYP2C9—Fluorouracil—urinary bladder cancer	0.0228	0.0375	CbGbCtD
Clopidogrel—CYP1A2—Etoposide—urinary bladder cancer	0.0211	0.0347	CbGbCtD
Clopidogrel—CYP2C9—Cisplatin—urinary bladder cancer	0.0194	0.0318	CbGbCtD
Clopidogrel—ABCB1—Cisplatin—urinary bladder cancer	0.0188	0.0309	CbGbCtD
Clopidogrel—ABCB1—Etoposide—urinary bladder cancer	0.0185	0.0304	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—urinary bladder cancer	0.0126	0.0207	CbGbCtD
Clopidogrel—ABCB1—Methotrexate—urinary bladder cancer	0.0122	0.0201	CbGbCtD
Clopidogrel—CYP3A4—Etoposide—urinary bladder cancer	0.0111	0.0182	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—urinary bladder cancer	0.00754	0.0124	CbGbCtD
Clopidogrel—Ticlopidine—MPO—urinary bladder cancer	0.0057	1	CrCbGaD
Clopidogrel—P2RY12—prostate gland—urinary bladder cancer	0.00557	0.126	CbGeAlD
Clopidogrel—CYP2C19—urine—urinary bladder cancer	0.00456	0.103	CbGeAlD
Clopidogrel—P2RY12—epithelium—urinary bladder cancer	0.00409	0.0923	CbGeAlD
Clopidogrel—CYP1A2—urine—urinary bladder cancer	0.00372	0.084	CbGeAlD
Clopidogrel—CYP2C9—urine—urinary bladder cancer	0.00354	0.0798	CbGeAlD
Clopidogrel—CES1—prostate gland—urinary bladder cancer	0.00292	0.066	CbGeAlD
Clopidogrel—CYP3A4—urine—urinary bladder cancer	0.0027	0.0608	CbGeAlD
Clopidogrel—CES1—female reproductive system—urinary bladder cancer	0.0016	0.036	CbGeAlD
Clopidogrel—CYP3A5—prostate gland—urinary bladder cancer	0.00129	0.0291	CbGeAlD
Clopidogrel—CYP2C8—renal system—urinary bladder cancer	0.000974	0.022	CbGeAlD
Clopidogrel—CES1—lymph node—urinary bladder cancer	0.000934	0.0211	CbGeAlD
Clopidogrel—CYP1A2—renal system—urinary bladder cancer	0.000911	0.0206	CbGeAlD
Clopidogrel—CYP3A5—renal system—urinary bladder cancer	0.000879	0.0198	CbGeAlD
Clopidogrel—CYP2B6—renal system—urinary bladder cancer	0.000874	0.0197	CbGeAlD
Clopidogrel—CYP2C19—vagina—urinary bladder cancer	0.000808	0.0182	CbGeAlD
Clopidogrel—CYP2C8—female reproductive system—urinary bladder cancer	0.00078	0.0176	CbGeAlD
Clopidogrel—CYP2C8—vagina—urinary bladder cancer	0.000705	0.0159	CbGeAlD
Clopidogrel—CYP2B6—female reproductive system—urinary bladder cancer	0.0007	0.0158	CbGeAlD
Clopidogrel—CYP2C9—female reproductive system—urinary bladder cancer	0.000693	0.0156	CbGeAlD
Clopidogrel—ABCB1—prostate gland—urinary bladder cancer	0.000685	0.0155	CbGeAlD
Clopidogrel—CYP3A4—renal system—urinary bladder cancer	0.00066	0.0149	CbGeAlD
Clopidogrel—CYP3A5—vagina—urinary bladder cancer	0.000637	0.0144	CbGeAlD
Clopidogrel—CYP2B6—vagina—urinary bladder cancer	0.000633	0.0143	CbGeAlD
Clopidogrel—ABCB1—seminal vesicle—urinary bladder cancer	0.000579	0.0131	CbGeAlD
Clopidogrel—CYP3A4—female reproductive system—urinary bladder cancer	0.000528	0.0119	CbGeAlD
Clopidogrel—ABCB1—epithelium—urinary bladder cancer	0.000503	0.0114	CbGeAlD
Clopidogrel—ABCB1—renal system—urinary bladder cancer	0.000467	0.0105	CbGeAlD
Clopidogrel—ABCB1—urethra—urinary bladder cancer	0.000459	0.0103	CbGeAlD
Clopidogrel—ABCB1—female reproductive system—urinary bladder cancer	0.000374	0.00844	CbGeAlD
Clopidogrel—ABCB1—vagina—urinary bladder cancer	0.000338	0.00763	CbGeAlD
Clopidogrel—ABCB1—lymph node—urinary bladder cancer	0.000219	0.00494	CbGeAlD
Clopidogrel—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000165	0.000697	CcSEcCtD
Clopidogrel—Body temperature increased—Cisplatin—urinary bladder cancer	0.000165	0.000697	CcSEcCtD
Clopidogrel—Fatigue—Etoposide—urinary bladder cancer	0.000165	0.000696	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000164	0.000696	CcSEcCtD
Clopidogrel—Stomatitis—Epirubicin—urinary bladder cancer	0.000163	0.000692	CcSEcCtD
Clopidogrel—Pain—Etoposide—urinary bladder cancer	0.000163	0.00069	CcSEcCtD
Clopidogrel—Constipation—Etoposide—urinary bladder cancer	0.000163	0.00069	CcSEcCtD
Clopidogrel—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000163	0.00069	CcSEcCtD
Clopidogrel—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000163	0.00069	CcSEcCtD
Clopidogrel—Neutropenia—Doxorubicin—urinary bladder cancer	0.000163	0.000689	CcSEcCtD
Clopidogrel—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000162	0.000685	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000162	0.000684	CcSEcCtD
Clopidogrel—Haemoglobin—Methotrexate—urinary bladder cancer	0.000162	0.000684	CcSEcCtD
Clopidogrel—Haemorrhage—Methotrexate—urinary bladder cancer	0.000161	0.000681	CcSEcCtD
Clopidogrel—Hepatitis—Methotrexate—urinary bladder cancer	0.000161	0.000681	CcSEcCtD
Clopidogrel—Asthenia—Gemcitabine—urinary bladder cancer	0.00016	0.000678	CcSEcCtD
Clopidogrel—Haematuria—Epirubicin—urinary bladder cancer	0.00016	0.000677	CcSEcCtD
Clopidogrel—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000159	0.000672	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000159	0.000671	CcSEcCtD
Clopidogrel—Epistaxis—Epirubicin—urinary bladder cancer	0.000158	0.000669	CcSEcCtD
Clopidogrel—Pruritus—Gemcitabine—urinary bladder cancer	0.000158	0.000669	CcSEcCtD
Clopidogrel—Nausea—Thiotepa—urinary bladder cancer	0.000158	0.000668	CcSEcCtD
Clopidogrel—Urethral disorder—Methotrexate—urinary bladder cancer	0.000158	0.000667	CcSEcCtD
Clopidogrel—Sinusitis—Epirubicin—urinary bladder cancer	0.000157	0.000666	CcSEcCtD
Clopidogrel—Feeling abnormal—Etoposide—urinary bladder cancer	0.000157	0.000665	CcSEcCtD
Clopidogrel—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000157	0.000662	CcSEcCtD
Clopidogrel—Pneumonia—Doxorubicin—urinary bladder cancer	0.000156	0.00066	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000156	0.00066	CcSEcCtD
Clopidogrel—Pruritus—Fluorouracil—urinary bladder cancer	0.000155	0.000658	CcSEcCtD
Clopidogrel—Visual impairment—Methotrexate—urinary bladder cancer	0.000155	0.000656	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000154	0.000651	CcSEcCtD
Clopidogrel—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000153	0.000649	CcSEcCtD
Clopidogrel—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000153	0.000647	CcSEcCtD
Clopidogrel—Renal failure—Doxorubicin—urinary bladder cancer	0.000153	0.000645	CcSEcCtD
Clopidogrel—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000152	0.000644	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000152	0.000644	CcSEcCtD
Clopidogrel—Urticaria—Etoposide—urinary bladder cancer	0.000152	0.000641	CcSEcCtD
Clopidogrel—Haemoglobin—Epirubicin—urinary bladder cancer	0.000151	0.00064	CcSEcCtD
Clopidogrel—Stomatitis—Doxorubicin—urinary bladder cancer	0.000151	0.00064	CcSEcCtD
Clopidogrel—Rhinitis—Epirubicin—urinary bladder cancer	0.000151	0.000639	CcSEcCtD
Clopidogrel—Body temperature increased—Etoposide—urinary bladder cancer	0.000151	0.000638	CcSEcCtD
Clopidogrel—Abdominal pain—Etoposide—urinary bladder cancer	0.000151	0.000638	CcSEcCtD
Clopidogrel—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000151	0.000638	CcSEcCtD
Clopidogrel—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000151	0.000638	CcSEcCtD
Clopidogrel—Hepatitis—Epirubicin—urinary bladder cancer	0.000151	0.000637	CcSEcCtD
Clopidogrel—Haemorrhage—Epirubicin—urinary bladder cancer	0.000151	0.000637	CcSEcCtD
Clopidogrel—Eye disorder—Methotrexate—urinary bladder cancer	0.00015	0.000636	CcSEcCtD
Clopidogrel—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00015	0.000636	CcSEcCtD
Clopidogrel—Tinnitus—Methotrexate—urinary bladder cancer	0.00015	0.000635	CcSEcCtD
Clopidogrel—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00015	0.000634	CcSEcCtD
Clopidogrel—Asthenia—Cisplatin—urinary bladder cancer	0.000149	0.000632	CcSEcCtD
Clopidogrel—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000149	0.000629	CcSEcCtD
Clopidogrel—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000148	0.000628	CcSEcCtD
Clopidogrel—Haematuria—Doxorubicin—urinary bladder cancer	0.000148	0.000626	CcSEcCtD
Clopidogrel—Urethral disorder—Epirubicin—urinary bladder cancer	0.000148	0.000624	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000147	0.000621	CcSEcCtD
Clopidogrel—Epistaxis—Doxorubicin—urinary bladder cancer	0.000146	0.000619	CcSEcCtD
Clopidogrel—Angiopathy—Methotrexate—urinary bladder cancer	0.000146	0.000618	CcSEcCtD
Clopidogrel—Sinusitis—Doxorubicin—urinary bladder cancer	0.000146	0.000616	CcSEcCtD
Clopidogrel—Immune system disorder—Methotrexate—urinary bladder cancer	0.000145	0.000615	CcSEcCtD
Clopidogrel—Dizziness—Fluorouracil—urinary bladder cancer	0.000145	0.000615	CcSEcCtD
Clopidogrel—Visual impairment—Epirubicin—urinary bladder cancer	0.000145	0.000614	CcSEcCtD
Clopidogrel—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000145	0.000613	CcSEcCtD
Clopidogrel—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000145	0.000613	CcSEcCtD
Clopidogrel—Diarrhoea—Cisplatin—urinary bladder cancer	0.000143	0.000603	CcSEcCtD
Clopidogrel—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000142	0.000602	CcSEcCtD
Clopidogrel—Vomiting—Gemcitabine—urinary bladder cancer	0.000142	0.000601	CcSEcCtD
Clopidogrel—Mental disorder—Methotrexate—urinary bladder cancer	0.000141	0.000596	CcSEcCtD
Clopidogrel—Rash—Gemcitabine—urinary bladder cancer	0.000141	0.000596	CcSEcCtD
Clopidogrel—Dermatitis—Gemcitabine—urinary bladder cancer	0.000141	0.000596	CcSEcCtD
Clopidogrel—Eye disorder—Epirubicin—urinary bladder cancer	0.000141	0.000595	CcSEcCtD
Clopidogrel—Hypersensitivity—Etoposide—urinary bladder cancer	0.000141	0.000595	CcSEcCtD
Clopidogrel—Tinnitus—Epirubicin—urinary bladder cancer	0.00014	0.000594	CcSEcCtD
Clopidogrel—Malnutrition—Methotrexate—urinary bladder cancer	0.00014	0.000593	CcSEcCtD
Clopidogrel—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00014	0.000592	CcSEcCtD
Clopidogrel—Headache—Gemcitabine—urinary bladder cancer	0.00014	0.000592	CcSEcCtD
Clopidogrel—Vomiting—Fluorouracil—urinary bladder cancer	0.00014	0.000591	CcSEcCtD
Clopidogrel—Rhinitis—Doxorubicin—urinary bladder cancer	0.00014	0.000591	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—urinary bladder cancer	0.000139	0.000589	CcSEcCtD
Clopidogrel—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000139	0.000589	CcSEcCtD
Clopidogrel—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000139	0.000586	CcSEcCtD
Clopidogrel—Rash—Fluorouracil—urinary bladder cancer	0.000139	0.000586	CcSEcCtD
Clopidogrel—Dermatitis—Fluorouracil—urinary bladder cancer	0.000138	0.000586	CcSEcCtD
Clopidogrel—Headache—Fluorouracil—urinary bladder cancer	0.000138	0.000582	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000138	0.000582	CcSEcCtD
Clopidogrel—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000137	0.000581	CcSEcCtD
Clopidogrel—Asthenia—Etoposide—urinary bladder cancer	0.000137	0.000579	CcSEcCtD
Clopidogrel—Angiopathy—Epirubicin—urinary bladder cancer	0.000137	0.000578	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000137	0.000578	CcSEcCtD
Clopidogrel—Immune system disorder—Epirubicin—urinary bladder cancer	0.000136	0.000575	CcSEcCtD
Clopidogrel—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000136	0.000574	CcSEcCtD
Clopidogrel—Back pain—Methotrexate—urinary bladder cancer	0.000135	0.000573	CcSEcCtD
Clopidogrel—Pruritus—Etoposide—urinary bladder cancer	0.000135	0.000571	CcSEcCtD
Clopidogrel—Visual impairment—Doxorubicin—urinary bladder cancer	0.000134	0.000568	CcSEcCtD
Clopidogrel—Nausea—Gemcitabine—urinary bladder cancer	0.000133	0.000562	CcSEcCtD
Clopidogrel—Vomiting—Cisplatin—urinary bladder cancer	0.000132	0.00056	CcSEcCtD
Clopidogrel—Mental disorder—Epirubicin—urinary bladder cancer	0.000132	0.000558	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000132	0.000557	CcSEcCtD
Clopidogrel—Rash—Cisplatin—urinary bladder cancer	0.000131	0.000556	CcSEcCtD
Clopidogrel—Dermatitis—Cisplatin—urinary bladder cancer	0.000131	0.000555	CcSEcCtD
Clopidogrel—Malnutrition—Epirubicin—urinary bladder cancer	0.000131	0.000555	CcSEcCtD
Clopidogrel—Diarrhoea—Etoposide—urinary bladder cancer	0.000131	0.000552	CcSEcCtD
Clopidogrel—Nausea—Fluorouracil—urinary bladder cancer	0.000131	0.000552	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—urinary bladder cancer	0.00013	0.000551	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—urinary bladder cancer	0.00013	0.00055	CcSEcCtD
Clopidogrel—Anaemia—Methotrexate—urinary bladder cancer	0.000129	0.000548	CcSEcCtD
Clopidogrel—Flatulence—Epirubicin—urinary bladder cancer	0.000129	0.000546	CcSEcCtD
Clopidogrel—Back pain—Epirubicin—urinary bladder cancer	0.000127	0.000536	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—urinary bladder cancer	0.000126	0.000535	CcSEcCtD
Clopidogrel—Dizziness—Etoposide—urinary bladder cancer	0.000126	0.000534	CcSEcCtD
Clopidogrel—Muscle spasms—Epirubicin—urinary bladder cancer	0.000126	0.000533	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000126	0.000532	CcSEcCtD
Clopidogrel—Vertigo—Methotrexate—urinary bladder cancer	0.000126	0.000532	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000126	0.000531	CcSEcCtD
Clopidogrel—Leukopenia—Methotrexate—urinary bladder cancer	0.000125	0.00053	CcSEcCtD
Clopidogrel—Nausea—Cisplatin—urinary bladder cancer	0.000124	0.000523	CcSEcCtD
Clopidogrel—Cough—Methotrexate—urinary bladder cancer	0.000122	0.000517	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—urinary bladder cancer	0.000122	0.000516	CcSEcCtD
Clopidogrel—Vomiting—Etoposide—urinary bladder cancer	0.000121	0.000513	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—urinary bladder cancer	0.000121	0.000513	CcSEcCtD
Clopidogrel—Anaemia—Epirubicin—urinary bladder cancer	0.000121	0.000513	CcSEcCtD
Clopidogrel—Rash—Etoposide—urinary bladder cancer	0.00012	0.000509	CcSEcCtD
Clopidogrel—Dermatitis—Etoposide—urinary bladder cancer	0.00012	0.000509	CcSEcCtD
Clopidogrel—Headache—Etoposide—urinary bladder cancer	0.00012	0.000506	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—urinary bladder cancer	0.00012	0.000506	CcSEcCtD
Clopidogrel—Arthralgia—Methotrexate—urinary bladder cancer	0.000119	0.000504	CcSEcCtD
Clopidogrel—Chest pain—Methotrexate—urinary bladder cancer	0.000119	0.000504	CcSEcCtD
Clopidogrel—Myalgia—Methotrexate—urinary bladder cancer	0.000119	0.000504	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000118	0.000501	CcSEcCtD
Clopidogrel—Vertigo—Epirubicin—urinary bladder cancer	0.000118	0.000498	CcSEcCtD
Clopidogrel—Syncope—Epirubicin—urinary bladder cancer	0.000118	0.000497	CcSEcCtD
Clopidogrel—Leukopenia—Epirubicin—urinary bladder cancer	0.000117	0.000496	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—urinary bladder cancer	0.000117	0.000496	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000117	0.000493	CcSEcCtD
Clopidogrel—Palpitations—Epirubicin—urinary bladder cancer	0.000116	0.00049	CcSEcCtD
Clopidogrel—Confusional state—Methotrexate—urinary bladder cancer	0.000115	0.000488	CcSEcCtD
Clopidogrel—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000115	0.000487	CcSEcCtD
Clopidogrel—Cough—Epirubicin—urinary bladder cancer	0.000114	0.000484	CcSEcCtD
Clopidogrel—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000114	0.000484	CcSEcCtD
Clopidogrel—Infection—Methotrexate—urinary bladder cancer	0.000114	0.00048	CcSEcCtD
Clopidogrel—Nausea—Etoposide—urinary bladder cancer	0.000113	0.00048	CcSEcCtD
Clopidogrel—Hypertension—Epirubicin—urinary bladder cancer	0.000113	0.000479	CcSEcCtD
Clopidogrel—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000112	0.000474	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—urinary bladder cancer	0.000112	0.000474	CcSEcCtD
Clopidogrel—Myalgia—Epirubicin—urinary bladder cancer	0.000112	0.000472	CcSEcCtD
Clopidogrel—Arthralgia—Epirubicin—urinary bladder cancer	0.000112	0.000472	CcSEcCtD
Clopidogrel—Chest pain—Epirubicin—urinary bladder cancer	0.000112	0.000472	CcSEcCtD
Clopidogrel—Anxiety—Epirubicin—urinary bladder cancer	0.000111	0.00047	CcSEcCtD
Clopidogrel—Skin disorder—Methotrexate—urinary bladder cancer	0.000111	0.00047	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000111	0.000469	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—urinary bladder cancer	0.000109	0.000461	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—urinary bladder cancer	0.000109	0.00046	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—urinary bladder cancer	0.000109	0.000459	CcSEcCtD
Clopidogrel—Confusional state—Epirubicin—urinary bladder cancer	0.000108	0.000456	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—urinary bladder cancer	0.000107	0.000453	CcSEcCtD
Clopidogrel—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000107	0.000453	CcSEcCtD
Clopidogrel—Oedema—Epirubicin—urinary bladder cancer	0.000107	0.000453	CcSEcCtD
Clopidogrel—Hypotension—Methotrexate—urinary bladder cancer	0.000107	0.000452	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000107	0.000451	CcSEcCtD
Clopidogrel—Infection—Epirubicin—urinary bladder cancer	0.000106	0.00045	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—urinary bladder cancer	0.000106	0.000448	CcSEcCtD
Clopidogrel—Shock—Epirubicin—urinary bladder cancer	0.000105	0.000445	CcSEcCtD
Clopidogrel—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000105	0.000444	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—urinary bladder cancer	0.000105	0.000443	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000104	0.000441	CcSEcCtD
Clopidogrel—Skin disorder—Epirubicin—urinary bladder cancer	0.000104	0.00044	CcSEcCtD
Clopidogrel—Insomnia—Methotrexate—urinary bladder cancer	0.000103	0.000437	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—urinary bladder cancer	0.000103	0.000437	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—urinary bladder cancer	0.000103	0.000437	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—urinary bladder cancer	0.000103	0.000437	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—urinary bladder cancer	0.000103	0.000435	CcSEcCtD
Clopidogrel—Paraesthesia—Methotrexate—urinary bladder cancer	0.000103	0.000434	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000103	0.000434	CcSEcCtD
Clopidogrel—Dyspnoea—Methotrexate—urinary bladder cancer	0.000102	0.000431	CcSEcCtD
Clopidogrel—Dyspepsia—Methotrexate—urinary bladder cancer	0.000101	0.000426	CcSEcCtD
Clopidogrel—Hypotension—Epirubicin—urinary bladder cancer	0.0001	0.000423	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—urinary bladder cancer	9.98e-05	0.000422	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—urinary bladder cancer	9.9e-05	0.000419	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—urinary bladder cancer	9.9e-05	0.000419	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	9.87e-05	0.000418	CcSEcCtD
Clopidogrel—Fatigue—Methotrexate—urinary bladder cancer	9.86e-05	0.000417	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—urinary bladder cancer	9.83e-05	0.000416	CcSEcCtD
Clopidogrel—Pain—Methotrexate—urinary bladder cancer	9.77e-05	0.000414	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	9.75e-05	0.000412	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—urinary bladder cancer	9.74e-05	0.000412	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—urinary bladder cancer	9.71e-05	0.000411	CcSEcCtD
Clopidogrel—Insomnia—Epirubicin—urinary bladder cancer	9.68e-05	0.000409	CcSEcCtD
Clopidogrel—Skin disorder—Doxorubicin—urinary bladder cancer	9.61e-05	0.000407	CcSEcCtD
Clopidogrel—Paraesthesia—Epirubicin—urinary bladder cancer	9.61e-05	0.000406	CcSEcCtD
Clopidogrel—Dyspnoea—Epirubicin—urinary bladder cancer	9.54e-05	0.000403	CcSEcCtD
Clopidogrel—Feeling abnormal—Methotrexate—urinary bladder cancer	9.42e-05	0.000399	CcSEcCtD
Clopidogrel—Dyspepsia—Epirubicin—urinary bladder cancer	9.42e-05	0.000398	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Methotrexate—urinary bladder cancer	9.35e-05	0.000395	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—urinary bladder cancer	9.25e-05	0.000391	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	9.24e-05	0.000391	CcSEcCtD
Clopidogrel—Fatigue—Epirubicin—urinary bladder cancer	9.22e-05	0.00039	CcSEcCtD
Clopidogrel—Pain—Epirubicin—urinary bladder cancer	9.15e-05	0.000387	CcSEcCtD
Clopidogrel—Constipation—Epirubicin—urinary bladder cancer	9.15e-05	0.000387	CcSEcCtD
Clopidogrel—Urticaria—Methotrexate—urinary bladder cancer	9.08e-05	0.000384	CcSEcCtD
Clopidogrel—Abdominal pain—Methotrexate—urinary bladder cancer	9.04e-05	0.000382	CcSEcCtD
Clopidogrel—Body temperature increased—Methotrexate—urinary bladder cancer	9.04e-05	0.000382	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	9.02e-05	0.000382	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—urinary bladder cancer	8.95e-05	0.000379	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—urinary bladder cancer	8.89e-05	0.000376	CcSEcCtD
Clopidogrel—Dyspnoea—Doxorubicin—urinary bladder cancer	8.82e-05	0.000373	CcSEcCtD
Clopidogrel—Feeling abnormal—Epirubicin—urinary bladder cancer	8.82e-05	0.000373	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Epirubicin—urinary bladder cancer	8.75e-05	0.00037	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—urinary bladder cancer	8.71e-05	0.000369	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	8.55e-05	0.000362	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—urinary bladder cancer	8.53e-05	0.000361	CcSEcCtD
Clopidogrel—Urticaria—Epirubicin—urinary bladder cancer	8.5e-05	0.00036	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—urinary bladder cancer	8.46e-05	0.000358	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—urinary bladder cancer	8.46e-05	0.000358	CcSEcCtD
Clopidogrel—Body temperature increased—Epirubicin—urinary bladder cancer	8.46e-05	0.000358	CcSEcCtD
Clopidogrel—Abdominal pain—Epirubicin—urinary bladder cancer	8.46e-05	0.000358	CcSEcCtD
Clopidogrel—Hypersensitivity—Methotrexate—urinary bladder cancer	8.42e-05	0.000356	CcSEcCtD
Clopidogrel—Asthenia—Methotrexate—urinary bladder cancer	8.2e-05	0.000347	CcSEcCtD
Clopidogrel—Feeling abnormal—Doxorubicin—urinary bladder cancer	8.16e-05	0.000345	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	8.09e-05	0.000342	CcSEcCtD
Clopidogrel—Pruritus—Methotrexate—urinary bladder cancer	8.09e-05	0.000342	CcSEcCtD
Clopidogrel—Hypersensitivity—Epirubicin—urinary bladder cancer	7.88e-05	0.000333	CcSEcCtD
Clopidogrel—Urticaria—Doxorubicin—urinary bladder cancer	7.86e-05	0.000333	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—urinary bladder cancer	7.82e-05	0.000331	CcSEcCtD
Clopidogrel—Abdominal pain—Doxorubicin—urinary bladder cancer	7.82e-05	0.000331	CcSEcCtD
Clopidogrel—Diarrhoea—Methotrexate—urinary bladder cancer	7.82e-05	0.000331	CcSEcCtD
Clopidogrel—Asthenia—Epirubicin—urinary bladder cancer	7.68e-05	0.000325	CcSEcCtD
Clopidogrel—Pruritus—Epirubicin—urinary bladder cancer	7.57e-05	0.00032	CcSEcCtD
Clopidogrel—Dizziness—Methotrexate—urinary bladder cancer	7.56e-05	0.00032	CcSEcCtD
Clopidogrel—Diarrhoea—Epirubicin—urinary bladder cancer	7.32e-05	0.00031	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—urinary bladder cancer	7.29e-05	0.000309	CcSEcCtD
Clopidogrel—Vomiting—Methotrexate—urinary bladder cancer	7.27e-05	0.000307	CcSEcCtD
Clopidogrel—Rash—Methotrexate—urinary bladder cancer	7.21e-05	0.000305	CcSEcCtD
Clopidogrel—Dermatitis—Methotrexate—urinary bladder cancer	7.2e-05	0.000305	CcSEcCtD
Clopidogrel—Headache—Methotrexate—urinary bladder cancer	7.16e-05	0.000303	CcSEcCtD
Clopidogrel—Asthenia—Doxorubicin—urinary bladder cancer	7.1e-05	0.0003	CcSEcCtD
Clopidogrel—Dizziness—Epirubicin—urinary bladder cancer	7.07e-05	0.000299	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—urinary bladder cancer	7e-05	0.000296	CcSEcCtD
Clopidogrel—Vomiting—Epirubicin—urinary bladder cancer	6.8e-05	0.000288	CcSEcCtD
Clopidogrel—Nausea—Methotrexate—urinary bladder cancer	6.79e-05	0.000287	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—urinary bladder cancer	6.77e-05	0.000287	CcSEcCtD
Clopidogrel—Rash—Epirubicin—urinary bladder cancer	6.74e-05	0.000285	CcSEcCtD
Clopidogrel—Dermatitis—Epirubicin—urinary bladder cancer	6.74e-05	0.000285	CcSEcCtD
Clopidogrel—Headache—Epirubicin—urinary bladder cancer	6.7e-05	0.000284	CcSEcCtD
Clopidogrel—Dizziness—Doxorubicin—urinary bladder cancer	6.55e-05	0.000277	CcSEcCtD
Clopidogrel—Nausea—Epirubicin—urinary bladder cancer	6.35e-05	0.000269	CcSEcCtD
Clopidogrel—Vomiting—Doxorubicin—urinary bladder cancer	6.29e-05	0.000266	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—urinary bladder cancer	6.24e-05	0.000264	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—urinary bladder cancer	6.24e-05	0.000264	CcSEcCtD
Clopidogrel—Headache—Doxorubicin—urinary bladder cancer	6.2e-05	0.000262	CcSEcCtD
Clopidogrel—Nausea—Doxorubicin—urinary bladder cancer	5.88e-05	0.000249	CcSEcCtD
Clopidogrel—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	4.08e-05	0.000387	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NAT1—urinary bladder cancer	4.07e-05	0.000386	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	4.07e-05	0.000386	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—IL2—urinary bladder cancer	4.01e-05	0.00038	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4e-05	0.000379	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TERT—urinary bladder cancer	4e-05	0.000379	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.98e-05	0.000378	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	3.89e-05	0.000369	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	3.79e-05	0.000359	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	3.72e-05	0.000353	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.7e-05	0.000351	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	3.68e-05	0.000348	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	3.67e-05	0.000348	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—FGFR3—urinary bladder cancer	3.67e-05	0.000347	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.66e-05	0.000346	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.59e-05	0.00034	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—TYMP—urinary bladder cancer	3.58e-05	0.000339	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.57e-05	0.000339	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ESR1—urinary bladder cancer	3.56e-05	0.000337	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—TYMP—urinary bladder cancer	3.5e-05	0.000332	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	3.48e-05	0.00033	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NAT1—urinary bladder cancer	3.48e-05	0.00033	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.47e-05	0.000329	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.42e-05	0.000324	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.39e-05	0.000321	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.38e-05	0.000321	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.35e-05	0.000318	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.3e-05	0.000313	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—NAT2—urinary bladder cancer	3.24e-05	0.000307	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.23e-05	0.000306	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	3.18e-05	0.000301	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.17e-05	0.0003	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—NAT2—urinary bladder cancer	3.16e-05	0.0003	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.12e-05	0.000296	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CREBBP—urinary bladder cancer	3.12e-05	0.000296	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.12e-05	0.000295	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.08e-05	0.000292	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IGF1—urinary bladder cancer	3.08e-05	0.000292	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—EGFR—urinary bladder cancer	3.07e-05	0.000291	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.04e-05	0.000288	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.03e-05	0.000287	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.97e-05	0.000282	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.91e-05	0.000276	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—KRAS—urinary bladder cancer	2.9e-05	0.000275	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.89e-05	0.000274	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	2.86e-05	0.000271	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.83e-05	0.000268	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—RHOA—urinary bladder cancer	2.82e-05	0.000268	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—RRM2—urinary bladder cancer	2.79e-05	0.000265	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—NAT2—urinary bladder cancer	2.74e-05	0.00026	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—RRM2—urinary bladder cancer	2.73e-05	0.000259	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.71e-05	0.000257	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	2.7e-05	0.000256	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.7e-05	0.000256	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.68e-05	0.000254	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.68e-05	0.000254	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.64e-05	0.00025	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	2.64e-05	0.00025	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ERBB2—urinary bladder cancer	2.61e-05	0.000248	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.6e-05	0.000246	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.59e-05	0.000246	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.59e-05	0.000245	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.59e-05	0.000245	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.53e-05	0.00024	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.53e-05	0.00024	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.53e-05	0.00024	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2.51e-05	0.000238	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CXCL8—urinary bladder cancer	2.48e-05	0.000235	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.47e-05	0.000234	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.47e-05	0.000234	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—HRAS—urinary bladder cancer	2.46e-05	0.000233	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.46e-05	0.000233	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.45e-05	0.000232	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.45e-05	0.000232	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.41e-05	0.000229	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.39e-05	0.000227	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.39e-05	0.000226	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL2—urinary bladder cancer	2.37e-05	0.000224	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.37e-05	0.000224	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.37e-05	0.000224	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCND1—urinary bladder cancer	2.31e-05	0.000219	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MMP9—urinary bladder cancer	2.24e-05	0.000212	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CDKN1A—urinary bladder cancer	2.23e-05	0.000212	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.23e-05	0.000211	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PTEN—urinary bladder cancer	2.23e-05	0.000211	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.21e-05	0.00021	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.19e-05	0.000208	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.19e-05	0.000208	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.18e-05	0.000206	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.13e-05	0.000202	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EP300—urinary bladder cancer	2.13e-05	0.000201	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.12e-05	0.000201	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.11e-05	0.0002	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.11e-05	0.0002	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.11e-05	0.0002	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.09e-05	0.000198	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.09e-05	0.000198	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.09e-05	0.000198	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SRC—urinary bladder cancer	2.07e-05	0.000196	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.06e-05	0.000195	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.04e-05	0.000193	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.03e-05	0.000193	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.02e-05	0.000192	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.96e-05	0.000185	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.96e-05	0.000185	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.94e-05	0.000184	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.93e-05	0.000182	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.91e-05	0.000181	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.91e-05	0.000181	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.91e-05	0.000181	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.9e-05	0.00018	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.87e-05	0.000177	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MYC—urinary bladder cancer	1.85e-05	0.000176	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.85e-05	0.000175	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EGFR—urinary bladder cancer	1.81e-05	0.000172	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.78e-05	0.000169	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.78e-05	0.000169	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.77e-05	0.000168	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.77e-05	0.000167	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.74e-05	0.000165	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.73e-05	0.000164	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.73e-05	0.000164	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.71e-05	0.000162	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—KRAS—urinary bladder cancer	1.71e-05	0.000162	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.7e-05	0.000161	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.7e-05	0.000161	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.65e-05	0.000156	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.63e-05	0.000154	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.62e-05	0.000153	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.6e-05	0.000152	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.6e-05	0.000152	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.58e-05	0.00015	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.58e-05	0.000149	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.56e-05	0.000148	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.56e-05	0.000148	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.54e-05	0.000146	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.53e-05	0.000145	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.53e-05	0.000145	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.52e-05	0.000144	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.52e-05	0.000144	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—urinary bladder cancer	1.52e-05	0.000144	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.51e-05	0.000144	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.5e-05	0.000142	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.5e-05	0.000142	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.49e-05	0.000142	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.48e-05	0.00014	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.47e-05	0.00014	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.47e-05	0.000139	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.47e-05	0.000139	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.46e-05	0.000138	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HRAS—urinary bladder cancer	1.45e-05	0.000138	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.44e-05	0.000136	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.42e-05	0.000135	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.41e-05	0.000134	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.39e-05	0.000132	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.38e-05	0.000131	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.37e-05	0.00013	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.35e-05	0.000128	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.35e-05	0.000128	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.33e-05	0.000126	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.31e-05	0.000125	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.3e-05	0.000123	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.28e-05	0.000122	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.27e-05	0.000121	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.27e-05	0.000121	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.27e-05	0.00012	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.23e-05	0.000116	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.22e-05	0.000116	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.22e-05	0.000115	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.21e-05	0.000114	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.21e-05	0.000114	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.2e-05	0.000114	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.000113	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.19e-05	0.000113	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.19e-05	0.000113	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.18e-05	0.000112	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.18e-05	0.000112	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.18e-05	0.000111	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.18e-05	0.000111	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.16e-05	0.00011	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.16e-05	0.00011	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.15e-05	0.000109	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.14e-05	0.000108	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.14e-05	0.000108	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.13e-05	0.000107	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.12e-05	0.000106	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.11e-05	0.000106	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.11e-05	0.000105	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.1e-05	0.000104	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.1e-05	0.000104	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.1e-05	0.000104	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.08e-05	0.000102	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.07e-05	0.000101	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.05e-05	0.0001	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.04e-05	9.88e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.04e-05	9.85e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.04e-05	9.81e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.02e-05	9.71e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.91e-06	9.39e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	9.73e-06	9.23e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PPARG—urinary bladder cancer	9.7e-06	9.19e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—TYMS—urinary bladder cancer	9.52e-06	9.02e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NQO1—urinary bladder cancer	9.48e-06	8.98e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	9.41e-06	8.92e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	9.41e-06	8.92e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	9.32e-06	8.83e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GPX1—urinary bladder cancer	9.01e-06	8.54e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	9.01e-06	8.54e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	8.85e-06	8.39e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	8.81e-06	8.35e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PPARG—urinary bladder cancer	8.66e-06	8.2e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PPARG—urinary bladder cancer	8.45e-06	8.01e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	8.32e-06	7.88e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	8.32e-06	7.88e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CREBBP—urinary bladder cancer	8.12e-06	7.69e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7.9e-06	7.49e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PPARG—urinary bladder cancer	7.89e-06	7.48e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTEN—urinary bladder cancer	7.86e-06	7.45e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTEN—urinary bladder cancer	7.68e-06	7.28e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	7.63e-06	7.23e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	7.58e-06	7.19e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—EP300—urinary bladder cancer	7.5e-06	7.1e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.35e-06	6.96e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—EP300—urinary bladder cancer	7.33e-06	6.94e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	7.26e-06	6.88e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	7.26e-06	6.88e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.96e-06	6.59e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.83e-06	6.47e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	6.81e-06	6.45e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PPARG—urinary bladder cancer	6.75e-06	6.39e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTEN—urinary bladder cancer	6.65e-06	6.31e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTGS2—urinary bladder cancer	6.65e-06	6.3e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	6.48e-06	6.14e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.42e-06	6.08e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—EP300—urinary bladder cancer	6.35e-06	6.01e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	6.21e-06	5.89e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTEN—urinary bladder cancer	5.94e-06	5.63e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTEN—urinary bladder cancer	5.8e-06	5.49e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—EP300—urinary bladder cancer	5.66e-06	5.37e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—EP300—urinary bladder cancer	5.53e-06	5.24e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTEN—urinary bladder cancer	5.42e-06	5.13e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	5.31e-06	5.03e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.21e-06	4.93e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—EP300—urinary bladder cancer	5.16e-06	4.89e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5e-06	4.74e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTEN—urinary bladder cancer	4.63e-06	4.39e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—EP300—urinary bladder cancer	4.41e-06	4.18e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.1e-06	3.88e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.57e-06	3.38e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.41e-06	3.23e-05	CbGpPWpGaD
